[The anti-inflammatory effect of electroacupuncture in mice with spinal cord injury and molecular mechanism based on

Zhu-Xin Yang1, Si-Qin Huang1, Cheng-Lin Tang1

  • 1Chongqing Key Laboratory of Traditional Chinese Medicine for the Prevention and Cure of Metabolic Diseases, College of Traditional Chinese Medicine, Chongqing Medical University, Chongqing 400016, China.

Abstract

Insights

Electroacupuncture (EA) improves nerve function and reduces inflammation in spinal cord injury (SCI) mice. This therapy down-regulates inflammatory genes like Fabp4, Adipoq, and Pck1, potentially by regulating PPAR and Adipocytokine signaling pathways.

Area of Science:

  • Neuroscience
  • Biomedical Engineering
  • Molecular Biology

Context:

  • Spinal cord injury (SCI) leads to significant neurological deficits and pathological changes.
  • Current treatments for SCI have limited efficacy in promoting neural repair and reducing inflammation.
  • Electroacupuncture (EA) is a potential therapeutic modality for neurological disorders.

Purpose:

  • To investigate the therapeutic effects of EA on neural function and spinal cord pathology in a mouse model of SCI.
  • To elucidate the underlying molecular mechanisms of EA's anti-inflammatory action in SCI using bioinformatics and gene expression analysis.

Summary:

  • EA treatment significantly improved hindlimb locomotor function (Basso Mouse Scale score) and alleviated histopathological damage in SCI mice compared to the model group.
  • RNA sequencing and bioinformatics analysis identified 15 differentially expressed genes, including inflammation-related factors Fabp4, Adipoq, and Pck1, which were downregulated by EA.
  • EA intervention modulated the peroxisome proliferator-activated receptor (PPAR) and Adipocytokine signaling pathways, as indicated by gene enrichment analysis.

Impact:

  • EA demonstrates therapeutic potential for SCI by promoting nerve repair and reducing inflammation.
  • The findings highlight specific molecular targets (Fabp4, Adipoq, Pck1) and signaling pathways (PPAR, Adipocytokine) involved in EA's mechanism of action for SCI.
  • This study provides a foundation for further research into EA as a non-pharmacological treatment for spinal cord injuries.

Related Concept Videos